These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32555609)

  • 1. Correction: S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    Wu W; Sung CC; Yu P; Li J; Chung KKK
    PLoS One; 2020; 15(6):e0235296. PubMed ID: 32555609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-Nitrosylation of G protein-coupled receptor kinase 6 and Casein kinase 2 alpha modulates their kinase activity toward alpha-synuclein phosphorylation in an animal model of Parkinson's disease.
    Wu W; Sung CC; Yu P; Li J; Chung KKK
    PLoS One; 2020; 15(4):e0232019. PubMed ID: 32343709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.
    Liu P; Wang X; Gao N; Zhu H; Dai X; Xu Y; Ma C; Huang L; Liu Y; Qin C
    Brain Res; 2010 Jan; 1307():134-41. PubMed ID: 19852948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-induced oxidative stress contributes to α-synuclein phosphorylation and up-regulation via polo-like kinase 2 and casein kinase 2.
    Wang R; Wang Y; Qu L; Chen B; Jiang H; Song N; Xie J
    Neurochem Int; 2019 May; 125():127-135. PubMed ID: 30797969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease.
    Arawaka S; Wada M; Goto S; Karube H; Sakamoto M; Ren CH; Koyama S; Nagasawa H; Kimura H; Kawanami T; Kurita K; Tajima K; Daimon M; Baba M; Kido T; Saino S; Goto K; Asao H; Kitanaka C; Takashita E; Hongo S; Nakamura T; Kayama T; Suzuki Y; Kobayashi K; Katagiri T; Kurokawa K; Kurimura M; Toyoshima I; Niizato K; Tsuchiya K; Iwatsubo T; Muramatsu M; Matsumine H; Kato T
    J Neurosci; 2006 Sep; 26(36):9227-38. PubMed ID: 16957079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein phosphorylation as a therapeutic target in Parkinson's disease.
    Braithwaite SP; Stock JB; Mouradian MM
    Rev Neurosci; 2012 Mar; 23(2):191-8. PubMed ID: 22499677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress-induced phosphorylation, degradation and aggregation of alpha-synuclein are linked to upregulated CK2 and cathepsin D.
    Takahashi M; Ko LW; Kulathingal J; Jiang P; Sevlever D; Yen SH
    Eur J Neurosci; 2007 Aug; 26(4):863-74. PubMed ID: 17714183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient modification of alpha-synuclein serine 129 by protein kinase CK1 requires phosphorylation of tyrosine 125 as a priming event.
    Kosten J; Binolfi A; Stuiver M; Verzini S; Theillet FX; Bekei B; van Rossum M; Selenko P
    ACS Chem Neurosci; 2014 Dec; 5(12):1203-8. PubMed ID: 25320964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Voluntary and spontaneous facial mimicry toward other's emotional expression in patients with Parkinson's disease.
    Kang J; Derva D; Kwon DY; Wallraven C
    PLoS One; 2019; 14(5):e0217715. PubMed ID: 31136633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation.
    Bae EJ; Kim DK; Kim C; Mante M; Adame A; Rockenstein E; Ulusoy A; Klinkenberg M; Jeong GR; Bae JR; Lee C; Lee HJ; Lee BD; Di Monte DA; Masliah E; Lee SJ
    Nat Commun; 2018 Aug; 9(1):3465. PubMed ID: 30150626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Can Plasma α-Synuclein Help Us to Differentiate Parkinson's Disease from Essential Tremor?
    Albillos SM; Montero O; Calvo S; Solano B; Trejo JM; Cubo E
    Tremor Other Hyperkinet Mov (N Y); 2021 Jun; 11():24. PubMed ID: 34221699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.
    Wilkaniec A; Lenkiewicz AM; Czapski GA; Jęśko HM; Hilgier W; Brodzik R; Gąssowska-Dobrowolska M; Culmsee C; Adamczyk A
    Mol Neurobiol; 2019 Jan; 56(1):125-140. PubMed ID: 29681024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.
    PLOS ONE Staff
    PLoS One; 2017; 12(2):e0172775. PubMed ID: 28207857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
    Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
    J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LK6/Mnk2a is a new kinase of alpha synuclein phosphorylation mediating neurodegeneration.
    Zhang S; Xie J; Xia Y; Yu S; Gu Z; Feng R; Luo G; Wang D; Wang K; Jiang M; Cheng X; Huang H; Zhang W; Wen T
    Sci Rep; 2015 Jul; 5():12564. PubMed ID: 26220523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.
    Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH
    Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Identification of a Tumor Specific, Active-Site Mutation in Casein Kinase 1α by Chemical Proteomics.
    Okerberg ES; Hainley A; Brown H; Aban A; Alemayehu S; Shih A; Wu J; Patricelli MP; Kozarich JW; Nomanbhoy T; Rosenblum JS
    PLoS One; 2017; 12(2):e0172649. PubMed ID: 28199383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.